The largest database of trusted experimental protocols

5 protocols using celltiter glo atp based assay

1

Assessing Murine Leukemia Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell growth was assessed using the Cell-TiterGlo ATP-based assay (Promega). Luminescence was measured using a Fluostar Omega instrument (BMG-Labtech). Apoptosis was measured using a Caspase-Glo 3/7 assay (Promega), or by annexin V and propidium iodide staining by flow cytometry (eBioscience). Cellular DNA content was assessed by staining with propidium iodide (50 g/ml). Cells were analyzed by flow cytometry with a FACScan flow cytometer (BD) and FlowJo V10 (Tree Star) analytical software. At least 20,000 events were acquired, and all determinations were replicated at least twice.
To assess cell viability upon JQ-FT treatment, in vitro murine leukemia cells expressing NOTCH1 L1601P ΔPEST were cultured in Optimem medium supplemented with 10% FBS, 1% penicillin/streptomycin, and murine IL-7 (10 ng/ml) on a feeder layer of OP9 stromal cells. Viability was examined using the cell viability kit with counting beads from BD, gating out dead cells and particles. Results were analyzed using FlowJo software.
+ Open protocol
+ Expand
2

Cytotoxicity Assay with Cetuximab

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess cell viability and determine IC50 values, Promega’s CellTiter-Glo ATP-based assay was utilized. Cells were seeded at 10,000 cells/well in a 96-well plate (Falcon 96-well Clear Flat Bottom TC-treated Culture Microplate). Cetuximab was added on the day of seeding and the plate was incubated for 72 h. Plates were removed from the incubator and 50 µl of CellTiter-Glo reagent was added directly into the wells. Plates were incubated on a shaker at room temperature for 30 min. Luminescence was measured on a Synergy H1 reader (Biotek). Luminescence readings were normalized as a percentage of the control. Dose–response curves and IC50 values were estimated using the R package drc v3.0–1 [13 (link)].
+ Open protocol
+ Expand
3

Evaluating STAG1 Deletion on Ewing Sarcoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the effects of STAG1 deletion on cell viability in STAG2 mutant or STAG2 depleted Ewing sarcoma cells, cells were plated in 384-well plates at a concentration of 1000 cells per well in 50 μL of medium. Cell viability was measured by adding 10 μL of CellTiter-Glo ATP-based assay (Promega). Luminescence was read using the FLUOstar Omega microplate reader (BMG LabTech).
+ Open protocol
+ Expand
4

Cell Viability Assay for Bacterial Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured using the CellTiter Glo ATP-based assay (Promega). A549 cells were seeded the day prior at 2 × 104 cells/well in a 96-well plate, considering that the cell count roughly doubles with overnight incubation. THP-1 monocytes were differentiated using 25 μM PMA and seeded the day prior at 2 × 104 cells/well in a 96-well plate. A549 and THP-1 were infected at MOI 20 and MOI 10, respectively. The plates were centrifuged at 500 × g for 5 min for bacteria contact with cells, then infected with live bacteria at 37°C for 2 h. When infecting with β-H/C+ extract, we used 5 μl and infect for 1 h. At the end of the experimental infection, the media was aspirated, and CellTiter Glo substrate added. The plate was shaken for 30 s to lyse cells and release ATP content, then allowed to incubate at room temperature for 10 min prior to reading luminescence.
+ Open protocol
+ Expand
5

Evaluating Ewing Sarcoma Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the effects of perturbations on Ewing sarcoma cell viability, cells were plated in 384-well plates at a concentration of 1000 cells per well in 50 μL of medium. Cell viability was measured by adding 10 μL of Cell-Titer Glo ATP-based assay (Promega). Luminescence was read using the FLUOstar Omega microplate reader (BMG LabTech). VS-4718, GSK-1070916, and NVP-AEW541 were obtained from Selleck for in vitro treatment of cells. Cells undergoing apoptosis were stained with Annexin V using the Apoptosis Detection Kit-APC (eBioscience) and cellular DNA content was measured by propidium iodide staining (Invitrogen). For intracellular phospho-protein staining, cells were fixed and permeabilized using the BD Cytofix/Cytoperm Kit (BD Biosciences) and stained with phycoerythrin (PE) anti-phospho-S6 (S240, BD Biosciences) and analyzed by flow cytometry. A minimum of 10,000 stained cells were analyzed in all flow cytometry experiments. All experiments testing viability, apoptosis, cell cycle, and measurements of phosphorylation of S6 were performed with two or more experimental replicates and each experiment repeated a minimum of two times. Experiments shown are representative of experimental and biologic replicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!